EDAP TMS S.A. (FOCL:NASDAQ) closed at $4.37 on October 21, 2026, up 4.05% on the day. The stock trades 31.7% below its 52-week high of $6.40 and 149.7% above its 52-week low of $1.75. Over the past year, it gained 87.6%. EDAP TMS S.A. is part of the Health Care sector.
In 218 trading sessions since December 9, 2025, FOCL closed higher on 103 days (47%). Its best day was December 12, 2025 (+22.55%) and its worst was August 12, 2026 (-20.97%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer.
Find more stocks like FOCL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.